Literature DB >> 9698370

Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.

J Duranton1, C Adam, J G Bieth.   

Abstract

Uncontrolled proteolysis due to cathepsin G (cat G) may cause severe pathological disorders. Cat G is inhibited by alpha 1-antichymotrypsin (ACT) and alpha 1-proteinase inhibitor (alpha 1PI), two members of the serpin superfamily of proteins. To see whether these two inhibitors play a physiological proteolysis-preventing function, we have made a detailed kinetic investigation of their reaction with cat G. The kinetics of inhibition of cat G in the presence of inhibitor and substrate evidenced a two-step inhibition mechanism: E + I EI EI. The cat G/ACT interaction is described by Ki = 6.2 x 10(-)8 M and k2 = 2.8 x 10(-)2 s-1, while the cat G/alpha 1PI association is governed by Ki = 8.1 x 10(-)7 M and k2 = 5.5 x 10(-)2 s-1. The reliability of these kinetic constants was checked using a number of experiments which all gave consistent results: (i) both EI complexes were found to be enzymatically inactive, (ii) the Ki values were determined directly using initial velocity experiments of cat G-catalyzed hydrolysis of substrate in the presence of inhibitor, (iii) the second-order rate constants k2/Ki were measured using second-order inhibition experiments in the absence of substrate, and (iv) the ratio of the two second-order rate constants was determined by measuring the partition of cat G between the two fluorescently labeled serpins. Since the plasma concentrations of ACT and alpha 1PI are much higher than their Ki values, cat G released from neutrophils will be fully taken up as rapidly forming EI complexes, that is, 70% with ACT and 30% with alpha 1PI. Both ACT and alpha 1PI are thus physiological cat G inhibitors whose inhibitory potential does not depend on the formation of the stable inhibitory species EI characteristic of serpins. Such an in vivo inhibition mechanism might take place with other serpin/proteinase systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698370     DOI: 10.1021/bi980223q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant.

Authors:  Junya Miyata; Kenji Tani; Keiko Sato; Shinsaku Otsuka; Tomoyuki Urata; Battur Lkhagvaa; Chiyuki Furukawa; Nobuya Sano; Saburo Sone
Journal:  Rheumatol Int       Date:  2006-09-15       Impact factor: 2.631

Review 2.  Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques.

Authors:  Benjamin M Scott; William P Sheffield
Journal:  Protein Sci       Date:  2019-12-09       Impact factor: 6.725

3.  Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.

Authors:  Sanjib Bhattacharyya; Haiying Zhou; Derrick R Seiner; Kent S Gates
Journal:  Bioorg Med Chem       Date:  2010-06-30       Impact factor: 3.641

4.  Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Authors:  Tony K Y Lim; Kathleen M Anderson; Pawan Hari; Marcos Di Falco; Troy E Reihsen; George L Wilcox; Kumar G Belani; Sylvie LaBoissiere; Manuel R Pinto; David S Beebe; Lois J Kehl; Laura S Stone
Journal:  J Pain       Date:  2017-06-24       Impact factor: 5.820

Review 5.  Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Authors:  Ignacio Blanco; Beatriz Lara; Frederick de Serres
Journal:  Orphanet J Rare Dis       Date:  2011-04-12       Impact factor: 4.123

6.  The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidases.

Authors:  Stephen C Pak; Christopher Tsu; Cliff J Luke; Yuko S Askew; Gary A Silverman
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

7.  The SANT2 domain of the murine tumor cell DnaJ-like protein 1 human homologue interacts with alpha1-antichymotrypsin and kinetically interferes with its serpin inhibitory activity.

Authors:  Barbara Kroczynska; Christina M Evangelista; Shalaka S Samant; Ebrahim C Elguindi; Sylvie Y Blond
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

8.  New chromogenic substrates of human neutrophil cathepsin G containing non-natural aromatic amino acid residues in position P(1) selected by combinatorial chemistry methods.

Authors:  Magdalena Wysocka; Anna Legowska; Elzbieta Bulak; Anna Jaśkiewicz; Hanna Miecznikowska; Adam Lesner; Krzysztf Rolka
Journal:  Mol Divers       Date:  2007-07-25       Impact factor: 2.943

9.  Association between alpha-1 antichymotrypsin gene A/T polymorphism and primary intracerebral hemorrhage: a meta-analysis.

Authors:  Zusen Ye; Qiang Ye; Bei Shao; Jincai He; Zhenguo Zhu; Jianhua Cheng; Yanyan Chen; Siyan Chen; Xiaoya Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Authors:  Toshiyuki Amano; Satoshi Inoha; Chun-Ming Wu; Toshio Matsushima; Kiyonobu Ikezaki
Journal:  Childs Nerv Syst       Date:  2003-07-25       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.